SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) — Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.
- RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m. ET, and be available for 1×1 investor meetings. The webcast link for the fireside chat can be found at https://ir.augmedix.com/.
- Benchmark Healthcare House Call Conference (Virtual): Management will be available for 1×1 investor meetings on May 21.
- B. Riley Annual Institutional Investor Conference (Beverly Hills, CA): Management will participate in a fireside chat on May 22 at 9:00 a.m. PT, and be available for 1×1 investor meetings.
- William Blair Annual Growth Stock Conference (Chicago): Management will participate in a fireside chat on June 5 at 8:40 a.m. CDT, and be available for 1×1 investor meetings. The webcast link for the fireside chat can be found at https://ir.augmedix.com/.
For additional information or to request a meeting with management, please contact either your corresponding sales representative at the host firms or the Augmedix investor relations team.
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust.
The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support.
Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
